FDA Approves RSV Drug For Babies And Toddlers At Risk | Weather.com

FDA Approves RSV Drug For Babies And Toddlers At Risk

October 15, 2024

Updated: October 15, 2024, 12:00 pm EDTPublished: October 15, 2024, 12:00 pm EDT

The Food and Drug Administration approved Beyfortus, an injectible medicine that contains RSV antibodies. The drug is intended to help infants and toddlers under 2 years old fight off the virus.

Loading comments...

Trending

New Denali Sled Dog Puppies Named After National Parks

This Major World Capital Is Sinking 10 Inches A Year

0:33

Nature’s Prism Explained: The Fascinating Physics Of Rainbows

Family Clings To Tractor In Flood Before Daring Rescue

0:27

Home & Garden

The Spring Bug Invasion You Didn't Sign Up For

0:56

Don’t Make These Mistakes When Planting Your Spring Garden

0:35

When To Worry About Mold Growing In Your Home

0:38

Get Ahead For Spring With Essential Winter Garden Tips

0:30

Advertisement

Advertisement

Advertisement